coronary syndrome – Page 9 – Communicable Diseases Research

Effect of COVID-19 on the Organs

Anesthesiology

Published on 2020-08-032022-10-31
Journal: Cureus [Category] COVID-19,

“Missing” acute coronary syndrome hospitalizations during the COVID ‐19 era in Greece: Medical care avoidance combined with a true reduction in incidence?

Observational Study

Published on 2020-07-212022-10-04
Journal: Clinical Cardiology [Category] MERS, SARS, 임상,

A Phase 3 Open-label, Randomized, Controlled Study to Evaluate the Efficacy and Safety of Intravenously Administered Ravulizumab Compared with Best Supportive Care in Patients with COVID-19 Severe Pneumonia, Acute Lung Injury, or Acute Respiratory Distress Syndrome: A structured summary of a study protocol for a randomised controlled trial

Letter

Published on 2020-07-132022-10-29
Journal: Trials [Category] Coronavirus, SARS,

[키워드] 24 hour 48 hour Activation acute lung injury acute pneumonia acute respiratory distress syndrome Administered Adult age all-cause mortality Amendment antibodies antibody Antibody test anticipated antiviral therapy approval ARDS assessment assigned baseline Biomarker Blood cardiac disease Care change class Clinical improvement clinical study clinical trial complement Complement inhibitor component Computed tomography concealed Concentration conducted Confirmed Controlled coronary syndrome COVID-19 criteria current Day diagnosis of SARS-CoV-2 dialysis discharge dissemination dose Duration Efficacy element eligibility Endotracheal intubation EU Clinical Trial EudraCT evaluate the effect expected failure female patient Final fraction France Germany greater half-live hospital Hospitalization humanized Hypercoagulable state Immunoglobulin Infection Inflammatory inhibitor initiated intensive care Intubated intubation invasive Invasive mechanical ventilation investigator IVIG Japan Lung injury mechanical ventilation medication monoclonal multicenter Neisseria meningitidis Non-invasive number objective Open-label original outcome oxygen participant Patient patients randomized patients with COVID-19 Period peripheral capillary phase Placebo Pneumonia polymerase chain positive airway pressure presenting progression protocol randomised randomised controlled trial randomization randomization list Randomized randomized controlled study Randomly Ravulizumab receive recruitment registry Remdesivir renal respiratory respiratory distress Respiratory distress syndrome routine clinical care Safety screened Screening secondary Serious Adverse Events serum severe acute respiratory distress syndrome coronavirus 2 Severe acute respiratory syndrome severe COVID-19 severe pneumonia SOFA Spain SpO2 Sponsor stratified Study protocol supportive care survival The United States therapy time Treatment treatment-emergent adverse event Ultomiris United Kingdom ventricular Viral website with COVID-19 X-ray
[DOI] 10.1186/s13063-020-04548-z PMC 바로가기 [Article Type] Letter

Apical Takotsubo Cardiomyopathy in a COVID-19 Patient Presenting with Stroke: A Case Report and Pathophysiologic Insights

Article

Published on 2020-07-092022-10-27
Journal: American journal of medical case reports [Category] COVID-19,

Incidence of Stress Cardiomyopathy During the Coronavirus Disease 2019 Pandemic

Research

Published on 2020-07-092022-10-29
Journal: JAMA Network Open [Category] COVID-19, SARS,

[키워드] 95% CI age analyzed Cardiomyopathy catheterization Cleveland clinic cohort study control group coronary syndrome coronavirus disease COVID-19 COVID-19 pandemic determine examined exposure finding group health system hospital Hospitalized Importance incidence increase in interquartile range Laboratory measure median men Mortality no significant difference objective outcome pandemic participant Patient Percutaneous coronary intervention Point presenting proportion Psychological ranged rehospitalization Relevance Result retrospective cohort study setting significant increase significantly increased Stress syndrome timeline timelines
[DOI] 10.1001/jamanetworkopen.2020.14780 PMC 바로가기 [Article Type] Research

Disrupting the Electrical Circuit: New Onset Atrial Fibrillation in a Patient With Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)

Cardiology

Published on 2020-07-092022-10-31
Journal: Cureus [Category] COVID-19,

Off-the-shelf barrier for emergency intubation in the cardiac catheterization laboratory during the coronavirus disease 2019 (COVID-19) pandemic

코로나바이러스 질병 2019(COVID-19) 대유행 기간 동안 심장 도관 연구소에서 비상 삽관을 위한 기성품 장벽

Original Paper

Published on 2020-07-042022-09-12
Journal: Clinical Research in Cardiology [Category] MERS, 진단,

Management of Cardiovascular Disease Patients With Confirmed or Suspected COVID-19 in Limited Resource Settings

Original Research

Published on 2020-07-012022-10-31
Journal: Global Heart [Category] COVID-19,

[키워드] approach asymptomatic phase cardiovascular cardiovascular disease cardiovascular system Chagas disease clinical guideline Community Confirmed Consensus coronary syndrome coronavirus coronavirus disease COVID-19 COVID-19 illness COVID-19 patients CVD diabetes disease facilitate healthcare Healthcare professional heart failure hypertension individual interact International Limited Low income countries low resource settings management manifestation middle income countries myocardial injury National novel coronavirus disease outcome pandemic Patient patients with COVID-19 potential mechanism prognostic recommendation recommendations regions required Research resource respiratory SARS-CoV-2 setting severe COVID-19 susceptible Suspected Transmission transmitted
[DOI] 10.5334/gh.823 PMC 바로가기 [Article Type] Original Research

Clinical utility of cardiac troponin measurement in COVID-19 infection

Mini Review

Published on 2020-04-272022-10-27
Journal: Annals of Clinical Biochemistry [Category] COVID-19,

[키워드] acute respiratory syndrome Analytes cardiac troponin Cardiac troponin I cardiac troponin T cardiovascular disease cause clinical Concentration Confusion coronary syndrome COVID-19 COVID-19 infection COVID-19 patient creating cTn detrimental effect disease global pandemic greater higher risk human-to-human transmission increased mortality Interpretation Isolation majority mechanism Mental Mild-to-moderate Mortality Myocardial infarction novel coronavirus SARS-CoV-2 pathophysiological mechanism Patient physical activity positive public health emergency reported Respiratory disease SARS-CoV-2 severe disease progression severity social distancing Symptoms the disease treatment regimens troponin utility while
[DOI] 10.1177/0004563220921888 PMC 바로가기 [Article Type] Mini Review

Clinical utility of cardiac troponin measurement in COVID-19 infection

Mini Review

Published on 2020-04-272022-10-27
Journal: Annals of Clinical Biochemistry [Category] Coronavirus, COVID-19, MERS, SARS,

[키워드] acute respiratory syndrome Analytes cardiac troponin Cardiac troponin I cardiac troponin T cardiovascular disease cause clinical Concentration Confusion coronary syndrome COVID-19 COVID-19 infection COVID-19 patient creating cTn detrimental effect disease global pandemic greater higher risk human-to-human transmission increased mortality Interpretation Isolation majority mechanism Mental Mild-to-moderate Mortality Myocardial infarction novel coronavirus SARS-CoV-2 pathophysiological mechanism Patient physical activity positive public health emergency reported Respiratory disease SARS-CoV-2 severe disease progression severity social distancing Symptoms the disease treatment regimens troponin utility while
[DOI] 10.1177/0004563220921888 PMC 바로가기 [Article Type] Mini Review